Symptomatology, diagnosis, and treatment of multisystemic inflammatory syndrome in post covid-19 infants: literature review


  • Silvia Elizabeth Bautista-Vanegas Universidad Católica de Cuenca
  • Susana Janeth Peña Cordero Universidad Católica de Cuenca
  • Isabel Cristina Mesa-Cano Universidad Católica de Cuenca


Palabras clave:

multisystemic inflammatory syndrome, covid-19, symptomatology, diagnosis, children


In 2020, COVID-19-associated multisystem inflammatory syndrome in children was first reported, which can have a severe course and may require supportive care. Objective: To review the scientific literature on symptomatology, diagnosis, and treatment of multisystemic inflammatory syndrome in children with COVID-19. Methodology: A systematic review of publications indexed in the following browsers was performed: Pubmed, Scopus, Web of Science, since 2017, those that had some relation with the subject to be treated were chosen, in a complementary way this search was performed using the keywords. Results: A total of 26 articles related to the topic were found, reflecting that multisystemic inflammatory syndrome is present in a large percentage of children who suffered COVID-19, MIS is characterized by fever, gastrointestinal manifestations, changes in the oral mucosa and skin rash. Laboratory and imaging tests are used to diagnose this pathology. Treatment consists of applying mainly IV immunoglobulin. Conclusions: Being a pathology of recent appearance in children it is important to study it and define the different components for an adequate diagnosis and treatment.


Los datos de descargas todavía no están disponibles.


Rodríguez R, Rivera M. Multisystemic inflammatory syndrome associated with COVID-19 in children and adolescents. Rev Latinoam Infectología Pediátrica [Internet]. 2020 [cited 2021 Nov 29];33(3):115–8. Available from: DOI:

Van Doremalen N, Bushmaker T, Morris DH, Holbrook M, Gamble A, Williamson B, et al. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N Engl J Med [Internet]. 2020 Apr 16 [cited 2022 Jan 24];382(16):1564–7. Available from: DOI:

Organizacion Mundial de Salud O. Coronavirus [Internet]. Health Topics. 2019 [cited 2021 Nov 23]. p. 1–3. Available from:

Taffarel P, Jorro F, Rodríguez A, Widmer J, Meregallia C. Multisystem inflammatory syndrome in children related to COVID-19: An update regarding the presentation of two critically ill patients. Arch Argent Pediatr [Internet]. 2021 Feb 1 [cited 2021 Dec 4];119(1). Available from: DOI:

Álvarez P, Lara C, Urdiales A, Salamea I, Melan B, Carreño M, et al. COVID-19 y síndrome inflamatorio multisistémico en niños. Rev Latinoam Hipertens [Internet]. 2021 [cited 2021 Nov 23];15(2):168–72. Available from:

Raab C. Enfermedad de Kawasaki - Pediatría [Internet]. Manual MSD versión para profesionales. 2019 [cited 2021 Nov 23]. p. 2–4. Available from:ía/trastornos-diversos-en-lactantes-y-niños/enfermedad-de-kawasaki-ek

Fallas M, Fung P, Guzmán A, Vargas S, Quirós P. Síndrome inflamatorio multisistémico pediátrico. Rev Medica Sinerg [Internet]. 2021 May 1 [cited 2021 Nov 24];6(5):e664–e664. Available from: DOI:

Hernandez J, Herrera R, Lequerica P, Hernandez J, Herrera R, Lequerica P. ¿Qué sabemos de la enfermedad de Kawasaki y COVID 19? Andes Pediatr [Internet]. 2021 Mar 1 [cited 2021 Nov 23];92(2):281–7. Available from: DOI:

Urrútia G, Bonfill X. PRISMA declaration: A proposal to improve the publication of systematic reviews and meta-analyses. Med Clin (Barc). 2010 Oct 9;135(11):507–11. DOI:

Cobos A, Augustovski F. Declaración CONSORT 2010: actualización de la lista de comprobación para informar ensayos clínicos aleatorizados de grupos paralelos. Med Clin (Barc) [Internet]. 2011 Jul 23 [cited 2021 Nov 22];137(5):213–5. Available from: DOI:

Pérez E, Percy E. Síndrome inflamatorio multisistémico en niños asociado a COVID-19. Rev Cubana Pediatr [Internet]. 2021 Oct 1 [cited 2022 Jan 17];93(4). Available from:

Yagnam F, Izquierdo G, Villena R, González C, Drago M. Pediatric Multisystemic Inflammatory Syndrome Temporarily associated with COVID-19: Clinical characteristics and management in a Pediatric Critical Care Unit. Andes Pediatr Rev Chil Pediatr [Internet]. 2021 [cited 2021 Nov 29];92(3):395–405. Available from: DOI:

Sánchez R, Fatahi M, García E, Edo M, Alonso E. Clinical and radiological findings for the new multisystem inflammatory syndrome in children associated with COVID-19. Radiologia [Internet]. 2021 Jul [cited 2021 Nov 29];63(4):334–44. Available from: DOI:

De Coll L, Zamudio M, Nuñez Hector, Bernal R, Schult S, Corahua M, et al. COVID-19-associated multisystem inflammatory syndrome in children: case series at a pediatric hospital in Peru. Rev Peru Med Exp Salud Publica [Internet]. 2020 Jul 1 [cited 2022 Jan 17];37(3):559–65. Available from: DOI:

Ensinck G, Gregorio G, Flores RM, Crowe CI, Clerico Mosina P, Curi C, et al. Consensus on treatment of multisystemic inflammatory syndrome associated with COVID-19. Arch Argent Pediatr [Internet]. 2021 [cited 2022 Jan 17];119(4):S198–211. Available from:

Álvarez P, Urdiales A, Vélez I, Melan B, Carreño M, Fajardo I. Covid-19 and multisystem inflammatory syndrome in children. Rev Latinoam Hipertens [Internet]. 2021 [cited 2021 Nov 30];15(3):160–70. Available from:

Morilla L, Morel Z, Pavlicich V. Clinical characteristics of pediatric patients with COVID-19 in an emergency department [Internet]. Pediatría (Asunción). 2020 [cited 2021 Nov 30]. p. 124–31. Available from: DOI:

Götzinger F, Santiago B, Noguera A, Lanaspa M, Lancella L, Calò F, et al. COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study. Lancet Child Adolesc Heal [Internet]. 2020 Sep 1 [cited 2021 Nov 29];4(9):653–61. Available from:

García A, Antón J, Martínez J, Garcia G, Cortés B, Tagarro A. Spanish consensus document on diagnosis, stabilisation and treatment of pediatric multisystem inflammatory syndrome related to SARS-CoV-2 (SIM-PedS). An Pediatría (English Ed [Internet]. 2021 Feb 1 [cited 2021 Nov 29];94(2):116.e1-116.e11. Available from: DOI:

Ulloa R, Ivankovich G, Yamazaki M. Multisystem inflammatory syndrome associated with COVID19 in children and adolescents: calling for diagnosis. Rev Chilena Infectol [Internet]. 2020 Jun 1 [cited 2021 Nov 29];37(3):199–201. Available from: DOI:

Tolunay O, Çelik Ü, Arslan C, Orgun A, Demir H, Demir O, et al. Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19: A Case Series Experience in a Tertiary Care Hospital of Southern Turkey. J Trop Pediatr [Internet]. 2021 Apr 1 [cited 2021 Nov 29];67(2). Available from: DOI:

Shioji N, Aoyama K, Englesakis M, Annich G, Maynes J. Multisystem inflammatory syndrome in children during the coronavirus disease pandemic of 2019: a review of clinical features and acute phase management. J Anesth [Internet]. 2021 Aug 1 [cited 2021 Nov 29];35(4):563–70. Available from: DOI:

Izquierdo G, Cofré F, Poli C, Delpiano L, Conca N, Verdugo P, et al. Recommendations for the suspected diagnosis and management of Multisystemic Inflammatory Syndrome (MIS-C) in the context of a SARS-CoV-2 pandemic. Rev Chilena Infectol [Internet]. 2021 Jun 1 [cited 2021 Nov 29];38(3):370–80. Available from: DOI:

Verdugo P, Álvarez P, Aroca P, Montes V, Poli C, Tapia L, et al. Hematologic parameters and biomarkers predictors of severity in Multisystem Inflammatory Syndrome in children associated with SARS-CoV-2. Andes Pediatr Rev Chil Pediatr [Internet]. 2021 [cited 2021 Nov 29];92(3):382–8. Available from: DOI:

Feldstein L, Tenforde M, Friedman K, Newhams M, Rose EB, Dapul H, et al. Characteristics and Outcomes of US Children and Adolescents with Multisystem Inflammatory Syndrome in Children (MIS-C) Compared with Severe Acute COVID-19. JAMA - J Am Med Assoc [Internet]. 2021 Mar 16 [cited 2021 Nov 29];325(11):1074–87. Available from:

Whittaker E, Bamford A, Kenny J, Kaforou M, Jones CE, Shah P, et al. Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2. JAMA [Internet]. 2020 Jul 21 [cited 2022 Jan 20];324(3):259–69. Available from: DOI:

Verdoni L, Mazza A, Gervasoni A, Martelli L, Ruggeri M, Ciuffreda M, et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet [Internet]. 2020 Jun 6 [cited 2022 Jan 20];395(10239):1771–8. Available from: DOI:

Noval Rivas M, Porritt RA, Cheng MH, Bahar I, Arditi M. COVID-19–associated multisystem inflammatory syndrome in children (MIS-C): A novel disease that mimics toxic shock syndrome—the superantigen hypothesis. J Allergy Clin Immunol [Internet]. 2021 Jan 1 [cited 2022 Jan 20];147(1):57–9. Available from: DOI:

Antúnez O, Escamilla M, Figueroa A, Arteaga E, Lavariega M, Salcedo P, et al. COVID-19 and Multisystem Inflammatory Syndrome in Latin American Children: A Multinational Study. Pediatr Infect Dis J [Internet]. 2020 [cited 2022 Jan 21]; Available from: DOI:

Nijman RG, De Guchtenaere A, Koletzko B, Ross Russell R, Copley S, Titomanlio L, et al. Pediatric Inflammatory Multisystem Syndrome: Statement by the Pediatric Section of the European Society for Emergency Medicine and European Academy of Pediatrics. Front Pediatr. 2020 Aug 28;8:490. DOI:




Cómo citar

Bautista-Vanegas , S. E. ., Peña Cordero, S. J. ., & Mesa-Cano, I. C. . (2022). Symptomatology, diagnosis, and treatment of multisystemic inflammatory syndrome in post covid-19 infants: literature review. Pro Sciences: Revista De Producción, Ciencias E Investigación, 6(42), 263–278.




Artículos más leídos del mismo autor/a

1 2 3 > >>